Teva Pharmaceuticals Doesn't Have The Cash Flow To Pay Its Upcoming Debt
Teva Pharmaceutical, which once responded to price-fixing allegations with ‘polite f-u’ letters’ now doesn't have the cash flow to pay off $4.2 billion of debt that matures in 2021.
Refinancing…